首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France
【24h】

Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France

机译:法国初级保健中尿路感染,细菌种类和耐药性的流行病学

获取原文
获取原文并翻译 | 示例
           

摘要

General practitioners often have to manage urinary tract infections (UTI) with probabilistic treatments, although bacterial resistances are increasing. Therefore, the French Society of Infectious Diseases published new guidelines in 2014. The aim of this study was to investigate the bacterial epidemiology of UTI in the general population in primary care and analyse risk factors for Escherichia coli resistance to antibiotics. A cross-sectional study was conducted in 12 ambulatory laboratories. Patients over 18 years of age coming for urinalysis were included. Risk factors for UTI were collected using a questionnaire and the laboratory records. Bacteria meeting criteria for UTI were analysed. A positive urinalysis was found in 1119 patients, corresponding to 1125 bacterial isolates. The bacterial species were: E. coli (73 %), Enterococcus spp. (7 %), Klebsiella spp. (6 %), Proteus spp. (4 %), Staphylococcus spp. (3 %) and Pseudomonas spp. (2 %). Regardless of the bacteria, the most common resistance was that to co-trimoxazole: 27 % (95 % confidence interval [CI] = [0.24; 0.30]), followed by ofloxacin resistance: 16 % [0.14; 0.18]. Escherichia coli resistances to co-trimoxazole, ofloxacin, cefixime, nitrofurantoin and fosfomycin were, respectively, 25.5 % [0.23; 0.28], 17 % [0.14; 0.20], 5.6 % [0.04; 0.07], 2.2 % [0.01; 0.03] and 1.2 % [0.005; 0.02]. Independent risk factors for E. coli resistance to ofloxacin were age over 85 years (odds ratio [OR] = 3.08; [1.61; 5.87]) and a history of UTI in the last 6 months (OR = 2.34; [1.54; 3.52]). Our findings support the guidelines recommending fluoroquinolone sparing. The scarcity of E. coli resistance to fosfomycin justifies its use as a first-line treatment in acute cystitis. These results should be reassessed in a few years to identify changes in the bacterial epidemiology of UTI.
机译:尽管细菌耐药性不断增加,但是全科医生通常不得不通过概率治疗来管理尿路感染(UTI)。因此,法国传染病学会于2014年发布了新指南。本研究的目的是调查普通保健人群中泌尿道感染的细菌流行病学,并分析大肠埃希菌对抗生素耐药的危险因素。在12个门诊实验室进行了横断面研究。包括18岁以上的尿检患者。使用问卷和实验室记录来收集尿路感染的危险因素。分析符合UTI标准的细菌。在1119例患者中发现尿液分析阳性,对应于1125株细菌。细菌种类为:大肠杆菌(73%),肠球菌。 (7%),克雷伯菌属。 (6%),变形杆菌属。 (4%),葡萄球菌属。 (3%)和假单胞菌属。 (2%)。不管细菌是什么,最常见的耐药性是对复方新诺明的耐药率:27%(95%置信区间[CI] = [0.24; 0.30]),其次是氧氟沙星耐药率:16%[0.14; 0.18]。大肠杆菌对复方新诺明,氧氟沙星,头孢克肟,呋喃妥因和磷霉素的耐药性分别为25.5%[0.23; 0.28],17%[0.14; 0.20],5.6%[0.04; 0.07],2.2%[0.01; 0.03]和1.2%[0.005; 0.02]。大肠杆菌对氧氟沙星耐药的独立危险因素是年龄超过85岁(赔率[OR] = 3.08; [1.61; 5.87])和最近6个月的尿路感染史(OR = 2.34; [1.54; 3.52] )。我们的发现支持建议保留氟喹诺酮的指南。大肠杆菌对磷霉素的抗药性不足,证明其可作为急性膀胱炎的一线治疗药物。这些结果应在几年内重新评估,以鉴定UTI细菌流行病学的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号